Direct action antivirals are effective in the total eradication of HCV in renal transplants

Teresa Olea*, Inmaculada Castillo, Carlos Jiménez, Javier Bartolomé, María José Santana, JA Quiroga, Vicente Carreño and Rafael Selgas

Introduction: The main objective of our study was to analyze the effectiveness of antiviral treatment (conventional or with direct-acting antivirals (DAA)) for total eradication of Hepatitis C Virus (HCV) in kidney transplant (KT) recipients. DAA are known drugs that are approved by FDA for clinical and preclinical

investigations. The effi cacy was analyzed by testing for the presence of HCV- ribonucleic acid (RNA) in the pellets obtained after ultracentrifugation of follow-up plasma samples and in peripheral blood mononuclear cells (PBMC) from patients with HCV infection who had achieved a sustained virological response (SVR). The safety, and the renal and hepatic repercussions of the antiviral treatment were also evaluated.

Keywords:

Published on: Jul 22, 2019 Pages: 1-5

Full Text PDF Full Text HTML DOI: 10.17352/aaa.000005
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat